Direct endomyocardial injection of autologous bone marrow cells to treat ischaemic heart failure (END-HF)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to determine whether direct endomyocardial injection of autologous bone marrow cells is effective for enhancement of neovascularisation in patients with ischaemic heart failure.
Epistemonikos ID: b1d9aad87bc8515e555425ddf3c2a1cd327388b0
First added on: May 05, 2024